Skip to main content
OpenTrials
Completed

NCT Number: NCT05804942

Metabolic Response to Variations in Dietary Glycemic Index

The goal of this study is to compare metabolic response to variations in dietary glycemic index in healthy participants. The main questions it aims to answer are:

• What are the metabolic hunger and food intake responses to different levels of glycemic index on the background of otherwise constant macronutrient composition? Participants will come to the lab after an overnight fast and body composition will be tested by bio-impedance analysis and magnetic resonance imaging. They will then be randomized to eat one of three standardized breakfasts varying in the glycemic index. Circulating glucose levels will be monitored using a continuous glucose monitor and blood samples will be collected to measure metabolic and hormone factors in the serum. Participants will also rate their hunger at 0, 30, 60, 120, 180, 240 and 300 minutes. After 5 hours they will eat a free choice meal from a standardized selection buffet (test meal).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shenzhen Institutes of Advanced Technology

Shenzhen, Guangdong, China

About this study

The primary variable in this study is the food energy intake at the test meal consumed 5 hours after the dietary intervention meal on day1 of the experiment, compared to the intake of the same test meal consumed on day 0. The investigators performed a power analysis using this outcome measure to inform the sample size if the data were analysed using one-way ANOVA. The number of levels in the study is 3, the investigators set the effect size as a difference between means of the groups of 265 kJ. From a pilot study of repeated measurements across individuals the investigators observed the standard deviation of the difference between repeated intakes was 372 kJ. The investigators set the power value of the study at 80 %. This analysis suggested a sample of 39 individuals per group. To account for individuals potentially not completing the study, the investigators aimed to recruit 135 participants in total.

The experiment includes the pre-test, the dietary intervention and postprandial monitoring.

Pre-test. The participants will be fed a test meal (free choice from buffet) at noon the day before the experiment (day 0). The food preference and total energy intake will be assessed. On the experimental day (day 1), the participants will be asked to attend the laboratory in the morning after an overnight fast (10 hours fasting). The body composition will be measured using a bio-impedance and magnetic resonance imaging, Then the participants will be guided to wear a continuous glucose monitoring system (CGMS) and the CGMS is under initialization for 2 hours. Also, a peripheral venous catheter (PVC) will be placed in the back of the hand, upper arm or elbow socket and 6 ml of fasting peripheral blood will be drawn (0 min).

Dietary intervention. 60 male and 60 female participants will be randomly divided into three groups: low, moderate and high glycemic index groups. Each group consists of 20 males and females. They will be feed by standardized meal with constant fat, protein and carbohydrate % but differing in the source of the carbohydrates.

Postprandial test. The test includes the testing of physiological indices during and after the intervention meal. In addition to continuously recording the changes in blood glucose by CGMS, the hunger rate will be accessed at 30 minutes intervals and peripheral blood will be collected by PVC (6 ml each time) at 30, 60, 120, 180, 240 and 300 min after the meal. When the participants have finished the tests during 300 min, a test meal will be provided identical to that provided on day 0. The effect of the standard meal on the total energy intake and macronutrient (carbohydrate, protein, fat) supply will be accessed in absolute amounts and the change between day 0 and day 1.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adults (both men and women)
  • 18-40 years old
  • 18.5 ≤ BMI (body mass index)<24 kg/m2

Exclusion criteria

  • Those who have undergone surgery in the past 6 months.
  • People are requiring long-term medication.
  • People have metabolic diseases, like diabetes, hypoglycemia, gout, osteoporosis, et al.
  • Those who have recently lost weight for various medical reasons (e.g. cancer, etc.).
  • People are losing weight by tablets.
  • People are suffering from infectious diseases (e.g. HIV, etc.)
  • People have blood phobia, pathological hypo or hyper tension.
  • People with impaired glucose tolerance.
  • Pregnant and lactation women.
  • Those who are afflicted with claustrophobia.

Treatment and study plan

High Glycemic Index

Behavioral

Composition (by proportion of calories) of meal: 60% carbohydrate (glycemic index:>70), 20% fat and 20% protein.

Medium glycemic index

Behavioral

Composition (by proportion of calories) of meal: 60% carbohydrate (glycemic index:55-70), 20% fat and 20% protein.

Low Glycemic Index

Behavioral

Composition (by proportion of calories) of meal: 60% carbohydrate (glycemic index:<55), 20% fat and 20% protein.

Primary outcomes

  1. Change in energy intake of test meal between day 0 and day 1

    Time frame: Change in intake between day 0 and day 1

    The food intake will be assessed objectively by use of a feeding table. The test meal will be provided as lunch, and food types available on the table include staples, vegetables, mushrooms, meat, soy products, desserts, beverages and water. All types of food are unlimited. Food consumption will be recorded continuously by balances concealed under each food dish. The food energy density for each food will be measured by bomb calorimetry in kJ/g, and energy intake will be calculated as the product of the grams of each food eaten multiplied by the respective energy density and then summed, as kJ.

    This test meal intake is measured on day 0 and then a repeat test meal measure is made under identical conditions on day 1. On day 1 an intervention meal is also consumed five hours before the test meal is consumed. On day 0 no such meal is consumed. The outcome measure is the change in food intake (kJ) between day 0 and day 1 reflecting the impact of the intervention meal.

Secondary outcomes

  1. circulating hormones

    Time frame: fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.

    Nurses will collect the blood samples on day 1. Levels of circulating hormones (insulin, leptin, glycogen,etc) in the serum will be measured by ELISA(Bio Tek, Synergy4) in mmol/L.

  2. postprandial glucose

    Time frame: fasting glucose and postprandial glucose for 5 hours

    Standardized meal with different levels of glycemic index( low level: ≤ 55, moderate level: 55 < GI ≤ 70, high level: > 70) will be provided as breakfast on day 1. Independent of the GI, the energy supply ratio of macronutrients carbohydrate, protein and fat will be fixed at 60 %, 20 % and 20 % respectively. Glucose concentration after the standardized meal will be recorded by the continuous glucose monitoring system(Medtronic) in mmol/L during 5 hours.

  3. self reported hunger

    Time frame: fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.

    Self reported hunger will be tested by rating scale question.

  4. levels of circulating metabolic fuels

    Time frame: fasting, postprandial 30, 60, 120, 180, 240 and 300 minutes.

    Nurses will collect the blood samples on day 1. Circulating lactate, free-fatty acids, triglycerides etc in mmol/L will be measured by ELISA(Bio Tek, Synergy4).

Other outcomes

  1. fat mass tested by bioelectrical impedance analysis

    Time frame: pre measurement

    Fat mass will be tested by bioelectrical impedance analysis(Tanita, MC-980) in kg.

  2. fat mass tested by magnetic resonance imaging

    Time frame: pre measurement

    Fat mass will be tested by magnetic resonance imaging(Shanghai united imaging, uMR790) in %.

  3. fat free mass tested by bioelectrical impedance analysis

    Time frame: pre measurement

    Fat free mass will be tested by bioelectrical impedance analysis(Tanita, MC-980) in kg.

  4. fat free mass tested by magnetic resonance imaging

    Time frame: pre measurement

    Fat free mass will be tested by magnetic resonance imaging(Shanghai united imaging, uMR790) in %.

  5. sex difference in energy intake

    Time frame: pre measurement

    The impact of sex on energy intake will be explored by correlation analysis.

  6. sex difference in circulating hormones

    Time frame: pre measurement

    The impact of sex on circulating hormones will be explored by correlation analysis.

  7. sex difference in postprandial glucose

    Time frame: pre measurement

    The impact of sex on postprandial glucose will be explored by correlation analysis.

  8. sex difference in self reported hunger

    Time frame: pre measurement

    The impact of sex on self reported hunger will be explored by correlation analysis.

  9. sex difference in circulating metabolic fuels

    Time frame: pre measurement

    The impact of sex on circulating metabolic fuels will be explored by correlation analysis.

  10. sex difference in fat mass

    Time frame: pre measurement

    The impact of sex on fat mass will be explored by correlation analysis.

  11. sex difference in fat free mass

    Time frame: pre measurement

    The impact of sex on fat free mass will be explored by correlation analysis.

Sponsors and collaborators

Lead sponsor

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Apr 7, 2023
Registry last updated
Feb 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.